由于肺炎而复杂的冷球蛋白血症
Luka Kiguradze1, Elizabeth Onoprishvili1, Khatuna Shvelidze2
1Internal Medicine, David Tvildiani Medical University, Tbilisi, GEO.
Cureus
|January 10, 2025
概括
本案例研究详细介绍了一个患有低温球蛋白血症的患者,出现了肺炎和关节炎,而不是典型的脏问题. 早期诊断和免疫抑制剂治疗带来了良好的结果,突出了罕见的肺部表现.
科学领域:
- 类风湿病学 类风湿病学
- 肺部病理学 肺部病理学
- 腎臟病學 (nephrology) 是一種醫學專業.
背景情况:
- 低血球蛋白症是一种全身性血管炎,通常与C型肝炎病毒感染有关.
- 脏干扰,如凝聚氨基炎,是冷球蛋白血症的常见和严重并发症.
- 肺部和关节的表现也可能发生,但不经常被记录.
相关概念视频
Pneumonia III: Complications and Assessment
156
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
156
Pneumonia II: Pathophysiology
212
The pathophysiology of pneumonia involves the following steps:
212
Pneumonia IV: Management
298
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
298
Pneumonia I: Introduction
208
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
208
Pulmonary Tuberculosis II
211
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
211
Pleural Effusion II: Symptoms and Management
151
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
151


